The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Allakos Inc | COM | 01671P100 | 23,125 | 242,505 | SH | SOLE | 242,505 | 0 | 0 | ||
Aravive Inc | COM | 03890D108 | 7,875 | 576,066 | SH | SOLE | 576,066 | 0 | 0 | ||
Atreca Inc | COM | 04965G109 | 9,148 | 591,368 | SH | SOLE | 591,368 | 0 | 0 | ||
Bellus Health Inc | COM | 07987C204 | 3,693 | 488,858 | SH | SOLE | 488,858 | 0 | 0 | ||
Catabasis Pharmaceuticals Inc | COM | 14875P206 | 1,773 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
Hookipa Pharma Inc | COM | 43906K100 | 6,485 | 530,245 | SH | SOLE | 530,245 | 0 | 0 | ||
Intercept Pharmaceuticals Inc | COM | 45845P108 | 50,025 | 403,688 | SH | SOLE | 403,688 | 0 | 0 | ||
Iveric Bio, Inc. | COM | 46583P102 | 6,006 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
KalVista Pharmaceuticals Inc | COM | 483497103 | 2,110 | 118,500 | SH | SOLE | 118,500 | 0 | 0 | ||
Liquidia Technologies Inc | COM | 53635D202 | 4,097 | 958,466 | SH | SOLE | 958,466 | 0 | 0 | ||
Millendo Therapeutics Inc | COM | 60040X103 | 4,820 | 715,201 | SH | SOLE | 715,201 | 0 | 0 | ||
Odonate Therapeutics Inc | COM | 676079106 | 16,960 | 522,637 | SH | SOLE | 522,637 | 0 | 0 | ||
Pieris Pharmaceuticals Inc | COM | 720795103 | 2,549 | 704,226 | SH | SOLE | 704,226 | 0 | 0 | ||
Principia Biopharma Inc | COM | 74257L108 | 16,806 | 306,784 | SH | SOLE | 306,784 | 0 | 0 | ||
Springworks Therapeutics Inc | COM | 85205L107 | 25,153 | 653,502 | SH | SOLE | 653,502 | 0 | 0 | ||
Sunesis Pharmaceuticals Inc | COM | 867328700 | 2,005 | 5,938,215 | SH | SOLE | 5,938,215 | 0 | 0 | ||
Sutro BioPharma Inc | COM | 869367102 | 12,381 | 1,125,579 | SH | SOLE | 1,125,579 | 0 | 0 | ||
Syros Pharmaceuticals Inc | COM | 87184Q107 | 11,255 | 1,726,603 | SH | SOLE | 1,726,603 | 0 | 0 | ||
Urovant Sciences Ltd | COM | G9381B108 | 2,443 | 157,480 | SH | SOLE | 157,480 | 0 | 0 |